Zomedica shareholders reject 80-for-1 reverse stock split at special meeting

Zomedica Corp.

Share Consolidation Proposal required two-thirds approval; received only 39.44% 'for' votes.
Final vote: 136,067,529 (39.44%) For, 206,789,223 (59.95%) Against, 2,109,080 (0.61%) Abstain.
Proposal not approved; company retains no shareholder authorization for reverse split.
The reverse split was likely intended to address NYSE American minimum bid price compliance.
Failure to approve may increase risk of delisting from NYSE American.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Zomedica Corp. shareholders rejected Approve an amendment to the Company's Articles of Incorporation to effect a share consolidation (reverse split) at a ratio of 80-for-1 at the 2024-02-28 meeting.

Proposal: reverse split
Outcome: failed
Meeting: 2024-02-28

Exact text from the filing

Approve an amendment to the Company's Articles of Incorporation (“Articles”) to effect a share consolidation (reverse split) of our issued and outstanding Common Shares at a ratio of 80-for-1, the implementation and timing of which shall be subject to the discretion of our Board of Directors (the “Share Consolidation Proposal”). The final votes cast on the Share Consolidation Proposal were as follows: For: 136,067,529 39.44% Against: 206,789,223 59.95% Abstain: 2,109,080 0.61%

View on SEC.gov

327 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Zomedica Corp. filing history →

Source: SEC EDGAR

accession 0001654954-24-002358

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.